|Bid||1.2600 x 1200|
|Ask||1.3800 x 800|
|Day's range||1.2600 - 1.3710|
|52-week range||1.2200 - 16.2570|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma are part of Zacks top Analyst Blog
Let us take a look at some drug/biotech stocks, ANGN, APLT, BOLT, IKNA and LABP, which are poised to beat on first-quarter earnings.
CRISPR Therapeutics (CRSP) reports wider-than-expected Q1 loss. Revenues miss estimates.